Rosa Lombardi

Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity

Anna Ludovica Fracanzani, Salvatore Petta, Rosa Lombardi et al. · Clinical Gastroenterology and Hepatology · 2017 · 218 citations

Obesity, Metabolic Syndrome, Metabolic Associated Steatohepatitis +12

Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity

Anna Ludovica Fracanzani, Luca Valenti, Elisabetta Bugianesi et al. · Journal of Hepatology · 2010 · 117 citations · Full text

Obesity, Metabolic Syndrome, Metabolic Associated Steatohepatitis +14

Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study

Luigi Elio Adinolfi, Salvatore Petta, Anna Ludovica Fracanzani et al. · Atherosclerosis · 2020 · 95 citations

Viral Persistence, Hepatology, Cardiovascular Disease +13

Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver Disease

Salvatore Petta, Vincent Wai‐Sun Wong, Elisabetta Bugianesi et al. · The American Journal of Gastroenterology · 2019 · 92 citations · Full text

Liver fibrosis by FibroScan^® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes

Rosa Lombardi, Lorena Airaghi, Giovanni Targher et al. · Liver International · 2019 · 85 citations · Full text